2024年11月1日上午,药明巨诺-B公司(02126.hk)股价出现大涨,盘中一度上涨5.84%,股价最高触及1.44港元,成交金额约1亿港元。这引发了市场广泛关注。
虽然尚无权威消息源公布其股价大涨的具体原因,但分析人士指出,推动这一涨幅的主要因素可能与资金面有关。公开数据显示,当日该股开盘后资金流入达64.62万港元,远高于流出金额。这表明市场对该公司前景信心增强,资金加速流入,从而推升股价走高。
此外,分析指出作为细胞免疫领域的龙头企业,药明巨诺-B在业绩和产品管线方面表现突出,也为股价上涨奠定了基础。公司上季度虽然亏损,但依然保持了营收增长,且其CAR-T疗法产品倍诺达在华销售强劲。在行业复苏和政策利好的背景下,市场对公司长期增长前景充满信心,有利于股价持续走高。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.